BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
BillionToOne, Inc.NASDAQ: BLLN
Other Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Other current liabilities rises 69.4% from a year ago
Other current liabilities stood at $19.04M at the end of Q2 FY2026, up 69.4% from a year earlier and up 8.5% from the prior quarter.
Context
- Other current liabilities amounted to 2.6% of total assets at the end of Q2 FY2026, down 1.0 pp from a year earlier.
- Other current liabilities increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +69.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 20.44M USD
- Year-over-year change
- +207.9%
- 2-year CAGR
- +119.0%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 20.44M | +207.9% |
| FY2024 | 2024-12-31 | 6.64M | +55.7% |
| FY2023 | 2023-12-31 | 4.26M | — |
Other Current Liabilities vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 other current liabilities of $19.04M is the 5th highest of the 9 companies compared; the peer median is $25.14M.
- Its year-over-year change of +69.4% is the 4th highest of 9, against a peer median of -28.5%.
- Other current liabilities amounts to 2.6% of total assets for BLLN, versus a peer median of 2.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $115.58M | +78.6% | +17.5% | 4.3% | |
| Mar 2026 | $90.5M | +79.2% | +14.3% | 13.4% | |
| Mar 2026 | $53.65M | +775.7% | +25.4% | 4.6% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $49.16M | +38.4% | +0.4% | 10.2% |
BLLNBillionToOne, Inc. | Jun 2026 | $19.04M | +69.4% | — | 2.6% |
| Jun 2026 | $1.11M | -95.4% | -0.0% | 0.0% | |
| Jun 2026 | $662K | -98.3% | -7.9% | 0.0% | |
| Sep 2026 | $0 | -100.0% | +29.0% | 0.0% | |
| Jun 2026 | $0 | -100.0% | +58.9% | 0.0% | |
| Peer median (excluding BLLN) | $25.14M | -28.5% | +15.9% | 2.2% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.